Overview of the viral hepatitis problem.
Lok
Anna S F
AS
Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Kim
W Ray
WR
El-Serag
Hashem B
HB
Maddrey
Willis C
WC
D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use; D002353:Carrier State / Q000175:diagnosis; D017281:Cost of Illness; D005260:Female; D019694:Hepatitis B, Chronic / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D015994:Incidence; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
D000998:Antiviral Agents